What we do
DEVELOPING NEW DRUGS
We identify and develop drug candidates with innovative mechanisms of action. By differentiating our approach from existing treatments, we aim at offering new therapeutic options to patients.
Our therapeutic areas
The molecules we develop are lipid derivatives. The robust experience of our team in complex lipid biochemistry enables us to tap the pharmacological potential of these molecules.
Research and development
GAOMA is a biotech company founded in 2019 and based in Bron, close to Lyon, France. Our team is committed to transform scientific discoveries into adapted therapeutic solutions for patients.
More about us and our team
SfN NEUROSCIENCE, SAN DIEGO – NOV. 2022
GERLI – NOVEMBER 2022
GAO-3-02 REPORT - PUBLICATION IN EPILEPSIA